(Q36686976)

15 August 2017

title

Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment (English)

1 reference

15 August 2017

Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment (English)

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

12 June 2024

1 reference

E. M. Berns

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607564

12 June 2024

J. A. Foekens

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607564

12 June 2024

I. L. van Staveren

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607564

12 June 2024

W. L. van Putten

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607564

12 June 2024

H. Y. de Koning

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607564

12 June 2024

H. Portengen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607564

12 June 2024

J. G. Klijn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607564

12 June 2024

language of work or name

English

0 references

publication date

1 June 1995

1 reference

15 August 2017

14 June 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7607564

full work available at URL

12 June 2024

https://api.elsevier.com/content/article/PII:037811199400534Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

https://api.elsevier.com/content/article/PII:037811199400534Y?httpAccept=text/plain

12 June 2024

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

12 June 2024

1 reference

15 August 2017

volume

159

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

11-18

1 reference

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

15 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

12 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Prognostic factors in human primary breast cancer: comparison of c-myc and HER2/neu amplification

12 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer

12 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors

12 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer

12 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis

12 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer

12 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

12 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Nonparametric Estimation from Incomplete Observations

12 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Clinical breast cancer, new developments in selection and endocrine treatment of patients

12 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

The HER-2/neu oncogene in breast cancer: so what is new?

12 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Amplification of the int-2 gene in primary human breast tumors

12 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer

12 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

12 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

c-erbB-2 oncogene as a prognostic marker in breast cancer

12 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study

12 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

A paradigm for oncogene complementation in human breast cancer

12 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

12 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

12 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

12 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases

12 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/0378-1119(94)00534-Y

12 June 2024

Identifiers

1 reference

15 August 2017

1 reference